What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News What makes Aptar Pharma’s latest nasal drug delivery bet a potential market disruptor? Aptar Pharma teams up with Dianosic to advance a bioresorbable nasal scaffold platform for chronic sinus and rhinitis care. Find out how this could reshape treatment. byPallavi MadhirajuSeptember 6, 2025